Discussing the problems in carrying out multi-country studies, and the solutions

Discussing the problems in carrying out multi-country studies, and the solutions.

This article produced from comprehensive information about operations of  a company and how their services are perceived. The results confirmed that  are generally performing well, largely due to their transparent procurement procedures, competitive prices and highly motivated staff. They have won the trust of their customers, appreciation from ministries of health and good relationships with their founding church bodies. Among the major findings was that the proportion of the population served by 15 faith based  in 10 countries ranged from 25‐60%, with an average of 43%. This figure indicates that public medicines supply systems do not cover the entire population and that faith‐based supply organizations are a necessary complement to public systems. (One  was excluded from this calculation as it only supplied customers in other countries). Another key finding was that  behave like small business entities, with either elected or nominated boards or committees to oversee their work. The majority of  functions and the services offered were based on a mix of options, which was appreciated by customers and which allowed  to be more flexible in their own operations. For example, choices were offered in procurement practices, supply and funding sources, methods of inventory control and quality control testing, delivery systems and methods of customer payments. The study highlighted areas of weakness in some ʹ systems. These included quality assurance, computerized drug management information and rational use of medicines policies. In a number of , lack of adherence to good storage, distribution and drug donation practices created inefficiencies that affected the ʹ sustainability and increased their operating costs. Some  were hampered by having no business plan. During the feedback meeting, quality assurance was identified as the highest priority area in the action plan participants developed to improve  performance. Only half the  undertook regular quality control testing of the batches they procured and few retained batch samples for an agreed period of time. All  reported that they were unable to carry out full GMP site inspections of their suppliers. Half the  received drug donations for distribution to their customers free of charge, and the study revealed that these donations could create problems rather than responding to real needs. When communication and coordination between  and donors were inadequate, inappropriate donations adversely affected supply management, storage and distribution. ʹ financial systems had to cope with unforeseen costs and the reduced revenues generated for their revolving drug funds. Overall customer feedback about  services was positive, with all expressing their appreciation of the quality and price of products and the good personal relationships established. However, many customers indicated that only 0‐50% of the number of items and between 50‐100% of the quantities of items ordered were met by . The study showed that customers had multiple sources of supply besides  supply services and that they supplemented their stocks with government supplies or buying from private wholesalers. To improve  performance, all customers interviewed indicated that they needed to be offered a wider range of medicines and quantities. They wanted more information‐sharing on current prices and quantities of products in stock, and improved delivery services. All the customers indicated the need for technical assistance and supervisory visits to improve their management of medicines at health care facility level. Also requested were in service training courses on prescribing, dispensing and rational use of medicines, especially ARVs, and on drug supply management, quality issues, stock control and estimating drug needs. Government representatives greatly appreciated faith‐based ʹ contribution to supply systems. However, they indicated room for improvement in formal reporting and collaboration between  and their respective ministries of health, and for better drug donation policies. Licensing of  by national drug regulatory authorities was identified as one major step towards official recognition and increased collaboration with governments.Flags,

Advertisements

6 responses to “Discussing the problems in carrying out multi-country studies, and the solutions

  1. Hello, i feel that i saw you visited my blog so i came to return the want?
    .I am trying to to find things to enhance my web site!
    I suppose its ok to use some of your ideas!!

  2. Yes. It\’s extremely cmomon.One of the symptoms of undiagnosed diabetes mellitus is visual disturbances. Now that you\’ve been diagnosed, and have started treatment, this will enable your blood glucose levels to return to normal\’ or near normal\’.Unfortunately, raised blood glucose levels alter the osmotic process within the eye(s). (Osmosis is the transfer of liquid between a semi-permeable membrane, as is the case in the lens of the eye.) This affects the ability of the eye(s) to focus light onto the retina, the light sensitive membrane at the rear of the eye.Now that there\’s (hopefully) less glucose present, your lenses will be able to focus better.I\’m glad you\’ve noticed some positive difference already. May your progress continue.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s